E

Enanta Pharmaceuticals
D

ENTA

8.04000
USD
-0.34
(-4.00%)
مغلق
حجم التداول
14,171
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
171,513,654
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALX
    -3.180
    (-1.55%)
    202.620 USD
    A
    APLS
    -0.850
    (-3.00%)
    27.510 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    A
    ASND
    -2.390
    (-1.54%)
    152.440 USD
    A
    AXSM
    8.550
    (6.62%)
    137.720 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    C
    CRVS
    -0.22000
    (-4.99%)
    4.19000 USD
    M
    MCRB
    -0.01050
    (-1.29%)
    0.80400 USD
    المزيد
الأخبار
المقالات

العنوان: Enanta Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.